Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndromeRandomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome, Published online: 16 December 2018; doi:10.1038/s41375-018-0312-9Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

Source: Leukemia - December 16, 2018 Category: Hematology Authors: Jorge E. Cortes Florian H. Heidel Andrzej Hellmann Walter Fiedler B. Douglas Smith Tadeusz Robak Pau Montesinos Daniel A. Pollyea Pierre DesJardins Oliver Ottmann Weidong Wendy Ma M. Naveed Shaik A. Douglas Laird Mirjana Zeremski Ashleigh O ’Connell Geo Source Type: research